These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
566 related items for PubMed ID: 8603034
1. P450-dependent enzymes as targets for prostate cancer therapy. De Coster R, Wouters W, Bruynseels J. J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):133-43. PubMed ID: 8603034 [Abstract] [Full Text] [Related]
2. Anti-tumour effects and pharmacokinetic profile of 17-(5'-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesis. Nnane IP, Long BJ, Ling YZ, Grigoryev DN, Brodie AM. Br J Cancer; 2000 Jul; 83(1):74-82. PubMed ID: 10883671 [Abstract] [Full Text] [Related]
3. Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys. Yamaoka M, Hara T, Hitaka T, Kaku T, Takeuchi T, Takahashi J, Asahi S, Miki H, Tasaka A, Kusaka M. J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):115-28. PubMed ID: 22249003 [Abstract] [Full Text] [Related]
4. Ketoconazole and liarozole in the treatment of advanced prostatic cancer. Mahler C, Verhelst J, Denis L. Cancer; 1993 Feb 01; 71(3 Suppl):1068-73. PubMed ID: 8428329 [Abstract] [Full Text] [Related]
5. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer. Njar VC, Kato K, Nnane IP, Grigoryev DN, Long BJ, Brodie AM. J Med Chem; 1998 Mar 12; 41(6):902-12. PubMed ID: 9526564 [Abstract] [Full Text] [Related]
6. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ, Brodie AM. Cancer Res; 2000 Dec 01; 60(23):6630-40. PubMed ID: 11118046 [Abstract] [Full Text] [Related]
8. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis. Klus GT, Nakamura J, Li JS, Ling YZ, Son C, Kemppainen JA, Wilson EM, Brodie AM. Cancer Res; 1996 Nov 01; 56(21):4956-64. PubMed ID: 8895750 [Abstract] [Full Text] [Related]